Adient (NYSE:ADNT) Stock Price Target Lowered at UBS Group

Adient (NYSE:ADNT) had its target price decreased by analysts at UBS Group from $23.00 to $22.00 in a note issued to investors on Thursday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. UBS Group‘s price objective indicates a potential upside of 28.45% from the stock’s previous close.

Other equities research analysts have also recently issued research reports about the company. Wall Street Zen cut Adient from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. Zacks Research raised Adient from a “strong sell” rating to a “hold” rating in a report on Wednesday, September 16th. Morgan Stanley cut their price target on Adient from $22.00 to $21.00 and set an “equal weight” rating for the company in a report on Tuesday, August 18th. Barclays reduced their price objective on Adient from $25.00 to $22.00 and set an “equal weight” rating on the stock in a research report on Friday, October 9th. Finally, Citigroup decreased their price objective on Adient from $33.00 to $29.00 and set a “buy” rating on the stock in a research note on Tuesday, August 11th. Seven equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $24.60.

Adient Stock Down 0.4%

ADNT stock opened at $17.13 on Thursday. The company’s 50 day simple moving average is $17.82 and its 200-day simple moving average is $20.47. The firm has a market capitalization of $1.32 billion, a PE ratio of 9.19, a P/E/G ratio of 0.24 and a beta of 1.64. Adient has a 12 month low of $15.80 and a 12 month high of $27.32. The company has a debt-to-equity ratio of 1.21, a current ratio of 1.09 and a quick ratio of 0.91.

Adient (NYSE:ADNT) last issued its quarterly earnings data on Wednesday, November 4th. The company reported $0.52 earnings per share for the quarter, missing analysts’ consensus estimates of $0.64 by ($0.12). Adient had a positive return on equity of 7.35% and a negative net margin of 0.11%. The business had revenue of $3.73 billion for the quarter, compared to analysts’ expectations of $3.62 billion. During the same period last year, the business earned $0.52 earnings per share. The company’s revenue for the quarter was up 1.1% on a year-over-year basis. Equities analysts expect that Adient will post 3.11 earnings per share for the current fiscal year.

Insider Activity at Adient

In other news, Director Peter Carlin sold 7,843 shares of the business’s stock in a transaction that occurred on Wednesday, September 2nd. The shares were sold at an average price of $19.25, for a total value of $150,977.75. Following the completion of the transaction, the director owned 38,835 shares of the company’s stock, valued at $747,573.75. The trade was a 16.80% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.94% of the stock is currently owned by company insiders.

Institutional Trading of Adient

A number of hedge funds have recently bought and sold shares of ADNT. Dimensional Fund Advisors LP grew its stake in Adient by 5.1% in the 1st quarter. Dimensional Fund Advisors LP now owns 4,384,904 shares of the company’s stock worth $88,614,000 after acquiring an additional 211,843 shares during the period. Arrowstreet Capital Limited Partnership lifted its stake in shares of Adient by 17.2% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,293,353 shares of the company’s stock worth $46,349,000 after purchasing an additional 336,306 shares during the period. Bank of America Corp DE lifted its stake in shares of Adient by 61.7% during the 1st quarter. Bank of America Corp DE now owns 792,543 shares of the company’s stock worth $16,017,000 after purchasing an additional 302,538 shares during the period. Empowered Funds LLC boosted its holdings in shares of Adient by 23.5% during the first quarter. Empowered Funds LLC now owns 554,572 shares of the company’s stock worth $11,208,000 after purchasing an additional 105,435 shares during the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in shares of Adient by 179.3% during the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 527,356 shares of the company’s stock worth $10,658,000 after purchasing an additional 338,517 shares during the last quarter. Institutional investors and hedge funds own 92.44% of the company’s stock.

Adient Company Profile

Adient plc (NYSE: ADNT) is a global automotive supplier specializing in the design, development and manufacture of vehicle seating systems. The company supplies complete seating assemblies as well as components such as seat structures, mechanisms, foam, fabrics, leather and other trim materials.

Adient works with automakers and other automotive customers to provide seating solutions for passenger cars, trucks, sport utility vehicles and commercial vehicles. Its offerings are designed to support vehicle comfort, safety, styling, weight reduction and manufacturing efficiency, with products developed for both traditional and electrified vehicles.

The company was formed in 2016 through the separation of Johnson Controls’ automotive seating business.